RNF182 and non-small cell lung carcinoma: The reduced expression is linked closely to promoter methylation, as confirmed by methylation analyses in clinical tissues through public database and bisulfate genomic sequencing, indicating that promoter methylation is the principal regulatory mechanism of RNF182 inactivation in NSCLC.